Progress in the Reversal of Direct Oral Anticoagulants

PROGRAM DESCRIPTION In this activity, a three-faculty panel of experts discuss clinical situations with emergent needs for direct oral anticoagulant (DOAC) reversal. Faculty are featured via a video-recorded conference, complete ...

PROGRAM DESCRIPTION
In this activity, a three-faculty panel of experts discuss clinical situations with emergent needs for direct oral anticoagulant (DOAC) reversal. Faculty are featured via a video-recorded conference, complete with an accompanying PowerPoint presentation. This virtual forum provides an objective, non-judgmental review of adverse DOAC outcomes and systematic process changes regarding situations where DOAC reversal is warranted.Clinicians require comprehensive knowledge of available and emerging DOAC reversal agents to appropriately apply them in emergent clinical situations. The goal for this activity is to guide clinical decisions, ranging from application of reversal approaches to resumption of DOAC therapy and timing after a patient experiences bleeding or thromboembolism.

EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be able to:Outline current approaches and challenges to management of bleeding in patients receiving DOACsCompare and contrast available and emerging reversal agents for DOACs, including their mechanisms of action and available dataDiscuss approaches to DOAC reversal across diverse patient populations

---

Write the first review

Resource tags